{"id": "1344251944781697029", "creation": 1609329613.0, "user_id": "2826292747", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 1, "like_count": 7, "quote_count": 0}}, "text": "Sinopharm, said that a #COVID19 #vaccine candidate made by its Beijing Institute of Biological Products arm had an efficacy rate of 79 percent based on an interim analysis of Phase 3 trials https://t.co/jo8I6Qru76 via @nytimes", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}